Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY
    Journal Article

    Goldberg, S. L.; Cortes, J. E.; Gambacorti-Passerini, C.; Hehlmann, R.; Khoury, H. J.; Michallet, M.; Paquette, R. L.; Simonsson, B.; Zyczynski, T.; Foreman, A.; more...
    American Journal of Hematology (2017)

    Fulltext@MSK | Save
  • Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
    Journal Article

    Coombs, C. C.; Zehir, A.; Devlin, S. M.; Kishtagari, A.; Syed, A.; Jonsson, P.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; more...
    Cell Stem Cell (2017)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent Cobimetinib for adults with histiocytic disorders: Interim results
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Dogan, A.; Hyman, D. M.; Rampal, R.; Ulaner, G.; Brody, L.; Abdel-Wahab, O.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • The genomic landscape of leukemic transformation of myeloproliferative neoplasm
    Meeting Abstract

    Menghrajani, K.; Rapaport, F.; Famulare, C.; Patel, M.; Manshouri, T.; Verstovsek, S.; Levine, R.; Rampal, R.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Therapeutic TCR mimic monoclonal antibodies to intracellular oncogenic proteins
    Meeting Abstract

    Scheinberg, D. A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Trial in progress: A Phase I/II study of lintuzumab-Ac225 in older patients with untreated acute myeloid leukemia
    Meeting Abstract

    Jurcic, J. G.; Levy, M.; Park, J.; Ravandi, F.; Perl, A.; Pagel, J.; Smith, B. D.; Orozco, J.; Estey, E.; Kantarjian, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Five-year efficacy and safety of dasatinib and imatinib by baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) from DASISION
    Meeting Abstract

    Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E. L.; Abaskharoun, M.; Sy, O.; Saglio, G.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Oral asciminib (ABL001) vs bosutinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who received ≥ 2 prior tyrosine kinase inhibitors (TKIs): A multicenter, open-label, randomized, phase 3 study
    Meeting Abstract

    Mauro, M.; Boquimpani, C.; Minami, Y.; Réa, D.; Kemp, C.; Hsu Schmitz, S. F.; Gopalakrishna, P.; Hochhaus, A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Bosutinib (BOS) vs imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE trial
    Meeting Abstract

    Cortes, J.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • CML management in 2017
    Meeting Abstract

    Mauro, M. J.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save